Preclinical correction of human Fanconi anemia complementation group A bone marrow cells using a safety-modified lentiviral vector
Open Access
- 20 May 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Gene Therapy
- Vol. 17 (10), 1244-1252
- https://doi.org/10.1038/gt.2010.62
Abstract
One of the major hurdles for the development of gene therapy for Fanconi anemia (FA) is the increased sensitivity of FA stem cells to free radical-induced DNA damage during ex vivo culture and manipulation. To minimize this damage, we have developed a brief transduction procedure for lentivirus vector-mediated transduction of hematopoietic progenitor cells from patients with Fanconi anemia complementation group A (FANCA). The lentiviral vector FancA-sW contains the phosphoglycerate kinase promoter, the FANCA cDNA, and a synthetic, safety-modified woodchuck post transcriptional regulatory element (sW). Bone marrow mononuclear cells or purified CD34+ cells from patients with FANCA were transduced in an overnight culture on recombinant fibronectin peptide CH-296, in low (5%) oxygen, with the reducing agent, N-acetyl-L-cysteine (NAC), and a combination of growth factors, granulocyte colony-stimulating factor (G-CSF), Flt3 ligand, stem cell factor, and thrombopoietin. Transduced cells plated in methylcellulose in hypoxia with NAC showed increased colony formation compared with 21% oxygen without NAC (PPFANCA.Keywords
This publication has 33 references indexed in Scilit:
- Lentiviral-mediated Genetic Correction of Hematopoietic and Mesenchymal Progenitor Cells From Fanconi Anemia PatientsMolecular Therapy, 2009
- Long-term polyclonal and multilineage engraftment of methylguanine methyltransferase P140K gene-modified dog hematopoietic cells in primary and secondary recipientsBlood, 2009
- Reconstitution activity of hypoxic cultured human cord blood CD34-positive cells in NOG miceBiochemical and Biophysical Research Communications, 2009
- Defective homing is associated with altered Cdc42 activity in cells from patients with Fanconi anemia group ABlood, 2008
- Rapid Lentiviral Transduction Preserves the Engraftment Potential of Fanca−/− Hematopoietic Stem CellsMolecular Therapy, 2008
- Unique Integration Profiles in a Canine Model of Long-Term Repopulating Cells Transduced with Gammaretrovirus, Lentivirus, or Foamy VirusHuman Gene Therapy, 2007
- Lentiviral vector integration sites in human NOD/SCID repopulating cellsThe Journal of Gene Medicine, 2006
- Natural gene therapy in monozygotic twins with Fanconi anemiaBlood, 2006
- Functional Correction of Fanconi Anemia Group C Hematopoietic Cells by the Use of a Novel Lentiviral VectorMolecular Therapy, 2001
- Engraftment of Hematopoietic Progenitor Cells Transduced with the Fanconi Anemia Group C Gene (FANCC)Human Gene Therapy, 1999